Andrew Spencer
- Molecular Biology top 0.5%
- Hematology top 0.05%
- Oncology top 0.2%
- Immunology top 2%
- Genetics top 0.5%
- Co-authors
- Meletios Α. DimopoulosPieter SonneveldChristopher M. DobsonTiffany KhongVânia HungriaH. Miles PrinceRobert KnightZhinuan Yu
- Topics
- Multiple Myeloma Research and Treatments (246 papers)Protein Degradation and Inhibitors (97 papers)Peptidase Inhibition and Analysis (64 papers)
- Cited by
- HematologyOncologyMolecular Biology
- Partner nations
- AustraliaUnited StatesSpain
In The Last Decade
Andrew Spencer
390 papers receiving 14.1k citations
Hit Papers
Peers
Comparison fields: 5 of 160
- Molecular Biology 8.4k
- Hematology 7.2k
- Oncology 5.7k
- Immunology 1.3k
- Genetics 1.2k
Countries citing papers authored by Andrew Spencer
This map shows the geographic impact of Andrew Spencer's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Andrew Spencer with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Andrew Spencer more than expected).
Fields of papers citing papers by Andrew Spencer
This network shows the impact of papers produced by Andrew Spencer. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Andrew Spencer. The network helps show where Andrew Spencer may publish in the future.
Co-authorship network of co-authors of Andrew Spencer
This figure shows the co-authorship network connecting the top 25 collaborators of Andrew Spencer. A scholar is included among the top collaborators of Andrew Spencer based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Andrew Spencer. Andrew Spencer is excluded from the visualization to improve readability, since they are connected to all nodes in the network.
All Works
| # | Work | Indexed citations |
|---|---|---|
| 1 | 0 | |
| 2 | 2 | |
| 3 | 1 | |
| 4 | 9 | |
| 5 | 1 | |
| 6 | 3 | |
| 7 | 1 | |
| 8 | 6 | |
| 9 | 3 | |
| 10 | 6 | |
| 11 | 4 | |
| 12 | 28 | |
| 13 | 4 | |
| 14 | 39 | |
| 15 | 32 | |
| 16 | 126 | |
| 17 | 68 | |
| 18 | 25 | |
| 19 | 135 | |
| 20 | 182 |
About Andrew Spencer
Andrew Spencer is a scholar working on Hematology, Oncology and Genetics, having authored 409 papers that have together received 14.4k indexed citations. Recurring topics across this work include Multiple Myeloma Research and Treatments (246 papers), Protein Degradation and Inhibitors (97 papers) and Peptidase Inhibition and Analysis (64 papers). The work is most often cited by research in Hematology (7.2k citations), Oncology (5.7k citations) and Molecular Biology (8.4k citations). Andrew Spencer has collaborated with scholars based in Australia, United States and Spain. Frequent co-authors include Meletios Α. Dimopoulos, Pieter Sonneveld, Christopher M. Dobson, Tiffany Khong, Vânia Hungria, H. Miles Prince, Robert Knight, Zhinuan Yu, Jerome B. Zeldis and Marta Olesnyckyj. Their work appears in journals such as Nature, New England Journal of Medicine and Proceedings of the National Academy of Sciences.
Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.